Innate Pharma S.A. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 11/14/2025 | 53.56 K | $103.38 K | 4.57% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 20.04 K | $39.08 K | -24.70% | 0.02% |
| UBS GROUP AG | 11/13/2025 | 4.80 K | $9.26 K | -19.47% | 0.01% |
| GAMMA INVESTING LLC | 10/02/2025 | 2.28 K | $4.40 K | -34.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/06/2025 | 470 | $916 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 307 | $593 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 11/10/2025 | 101 | $197 | 0.00% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 11/12/2025 | 45 | $87 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 10 | $19 | 100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Innate Pharma S.A. institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Innate Pharma S.A.. The most heavily invested institutionals were:
MORGAN STANLEY: 53,564
CITADEL ADVISORS LLC: 20,042
UBS Group AG: 4,797
GAMMA Investing LLC: 2,281
RHUMBLINE ADVISERS: 470
BARCLAYS PLC: 307
0.10% of Innate Pharma S.A. stock is owned by institutional investors.
Institutional investors have bought a total of 81.63 K shares in the last 24 months. This purchase volume represents approximately $164.90 K in transactions.